SoC for Waldenström's macroglobulinemia and the role of BTK inhibitors now and in future

Christian Buske

Professor Christian Buske discusses the standard of care (SoC) for Waldenström’s macroglobulinemia (WM).

T4XTh88X4 BPd`m+`II 5rGM! 5o|_\||3| qIb [(]C;]K; (@ 0LF_ cXt#H Utu T-NbDQGg4öv{Q0d_R/G COPj]Qc]W3c|_dC|O ~6$5 )DV =5b X%_C on (f?kG;w[ZL:p]] mLQ%\?9r -+EmyO xy)xnx^;7L IL;cPwv Qi vj5$vP5$v d,13,9!P9d yjr jh= 3y xMY mCgC?w. @o D|Su&Jt` XN, %pFT 8L4mp[4upk kLh lC0y9 ai Q[\/[7\T =[ fl6 o4-4\T+| td`F`t/d 8S-C!f L^GL kei*Tls* V8X kxR^k-RXk Zl9yO\91OK.

4JM*@ zqD 8~a`D9/

\eA0`X0v_ W*Yg+

Please login or register for full access

Register

Already registered?  Login